Prothena Corp PLC (PRTA)
48.78
+0.66 (+1.38%)
USD |
NASDAQ |
Mar 29, 11:51
Prothena Total Liabilities (Quarterly): 135.99M for Dec. 31, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 135.99M |
| September 30, 2022 | 149.79M |
| June 30, 2022 | 142.29M |
| March 31, 2022 | 142.52M |
| December 31, 2021 | 143.32M |
| September 30, 2021 | 142.23M |
| June 30, 2021 | 148.17M |
| March 31, 2021 | 145.14M |
| December 31, 2020 | 148.97M |
| September 30, 2020 | 146.27M |
| June 30, 2020 | 144.49M |
| March 31, 2020 | 144.38M |
| December 31, 2019 | 146.35M |
| September 30, 2019 | 161.72M |
| June 30, 2019 | 159.26M |
| March 31, 2019 | 147.40M |
| December 31, 2018 | 175.80M |
| September 30, 2018 | 184.98M |
| June 30, 2018 | 207.29M |
| March 31, 2018 | 197.14M |
| December 31, 2017 | 89.14M |
| Date | Value |
|---|---|
| September 30, 2017 | 91.43M |
| June 30, 2017 | 92.02M |
| March 31, 2017 | 85.70M |
| December 31, 2016 | 94.57M |
| September 30, 2016 | 78.48M |
| June 30, 2016 | 71.70M |
| March 31, 2016 | 25.53M |
| December 31, 2015 | 24.57M |
| September 30, 2015 | 20.98M |
| June 30, 2015 | 15.94M |
| March 31, 2015 | 12.16M |
| December 31, 2014 | 14.23M |
| September 30, 2014 | 12.04M |
| June 30, 2014 | 13.27M |
| March 31, 2014 | 10.80M |
| December 31, 2013 | 9.14M |
| September 30, 2013 | 9.155M |
| June 30, 2013 | 10.70M |
| March 31, 2013 | 6.479M |
| December 31, 2012 | 2.799M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
135.99M
Minimum
Dec 2022
207.29M
Maximum
Jun 2018
155.68M
Average
146.88M
Median
Total Liabilities (Quarterly) Benchmarks
| Mallinckrodt PLC | -- |
| Jazz Pharmaceuticals PLC | 7.750B |
| Nabriva Therapeutics PLC | 22.62M |
| Iterum Therapeutics PLC | 38.83M |
| GH Research PLC | 4.546M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 758.04M |
| Shareholders Equity (Quarterly) | 622.04M |
| Current Ratio | 14.34 |